Trademark applications and grants for Achillion Pharmaceuticals Inc. Achillion Pharmaceuticals Inc has 8 trademark applications. The latest application filed is for "TOGETHER, WE ARE C3G"
Patent Application | Date |
---|---|
QUINAZOLINE AND INDOLE COMPOUNDS TO TREAT MEDICAL DISORDERS 20220119400 - 17/564446 WILES; Jason Allan ;   et al. | 2022-04-21 |
TARGETED DOSING FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS 20220079943 - 17/414057 Huang; Mingjun ;   et al. | 2022-03-17 |
MORPHIC FORMS OF COMPLEMENT FACTOR D INHIBITORS 20210332026 - 17/279767 Phadke; Avinash ;   et al. | 2021-10-28 |
MACROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS 20210300934 - 17/314155 WILES; Jason Allan ;   et al. | 2021-09-30 |
ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS 20210269458 - 17/015171 WILES; Jason Allan ;   et al. | 2021-09-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.